Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence

Journal of Virology

Volumn 79, Issue 16, 2005, Pages 10451-10459

  Grande Pérez, Ana ^a,c   Gómez Mariano, Gema ^a   Lowenstein, Pedro R ^b   Domingo, Esteban ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ANIMAL CELL; ARENAVIRUS; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION STRUCTURE; PRIORITY JOURNAL; PROGENY; SPECIES EXTINCTION; VIRUS GENE; VIRUS INFECTIVITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; FLUOROURACIL; GENOME, VIRAL; GUINEA PIGS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RNA, VIRAL;

ARENAVIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RNA VIRUSES;

EID: 23244443638     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.16.10451-10459.2005     Document Type: Article

References (92)

1. Aebischer, T., D. Moskophidis, U. H. Rohrer, R. M. Zinkernagel, and H. Hengartner. 1991. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 88:11047-11051.
2. Agol, V. I. 2002. Picornavirus genetics: an overview, p. 269-284. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. American Society for Microbiology, Washington, D.C.
3. Ahmed, R., and M. B. Oldstone. 1988. Organ-specific selection of viral variants during chronic infection. J. Exp. Med. 167:1719-1724.
4. Airaksinen, A., N. Pariente, L. Menendez-Arias, and E. Domingo. 2003. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagcnesis. Virology 311:339-349.
5. Alves, D., and J. F. Fontanari. 1998. Error threshold in finite populations. Phys. Rev. E 57:7008-7013.
6. Anderson, J. P., R. Daifuku, and L. A. Loeb. 2004. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58:183-205.
7. Auperin, D. D., V. Romanowski, M. Galinski, and D. H. Bishop. 1984. Sequencing studies of pichinde arenavirus S RNA indicate a novel coding strategy, an ambisense viral S RNA. J. Virol. 52:897-904.
8. Auperin, D. D., D. R. Sasso, and J. B. McCormick. 1986. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology 154:155-167.
9. Borrego, B., I. S. Novella, E. Giralt, D. Andreu, and E. Domingo. 1993. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J. Virol. 67:6071-6079.
10. Borrow, P., C. F. Evans, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059-1070.
11. Bruenn, J. A. 2003. A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res. 31:1821-1829.
12. Buchmeier, M. J., M. D. Bowen, and C. J. Peters. 2001. Arenaviridae: the viruses and their replication, p. 1635-1668. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
13. Cattaneo, R., and M. A. Billeter. 1992. Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176:63-74.
14. Chumakov, K. M., L. B. Powers, K. E. Noonan, I. B. Roninson, and I. S. Levenbook. 1991. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc. Natl. Acad. Sci. USA 88:199-203.
15. Ciurea, A., P. Klenerman, L. Hunziker, E. Horvath, B. M. Senn, A. F. Ochsenbein, H. Hengartner, and R. M. Zinkernagel. 2000. Viral persistence in vivo through selection of neutralizing antibody-escape variants. Proc. Natl. Acad. Sci. USA 97:2749-2754.
16. Clegg, J. C., S. M. Wilson, and J. D. Oram. 1991. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arena-virus gene products. Virus Res. 18:151-164.
17. Condit, C. 2001. Principles of virology, p. 811-815. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams and Wilkins, Philadelphia, Pa.
18. Contreras, A. M., Y. Hiasa, W. He, A. Terella, E. V. Schmidt, and R. T. Chung. 2002. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J. Virol. 76:8505-8517.
19. Crotty, S., C. Cameron, and R. Andino. 2002. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J. Mol. Med. 80:86-95.
20. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98:6895-6900.
21. Crotty, S., D. Maag, J. J. Arnold, W. Zhong, J. Y. N. Lau, Z. Hong, R. Andino, and C. E. Cameron. 2000. The broad-spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen. Nat. Med. 6:1375-1379.
22. de la Torre, J. C., and J. J. Holland. 1990. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64:6278-6281.
23. de la Torre, J. C., G. Rall, C. Oldstone, P. P. Sanna, P. Borrow, and M. B. Oldstone. 1993. Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons. J. Virol. 67:7350-7359.
24. Djavani, M., I. S. Lukashevich, and M. S. Salvato. 1998. Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea pigs. Virus Genes 17:151-155.
25. Djavani, M., I. S. Lukashevich, A. Sanchez, S. T. Nichol, and M. S. Salvato. 1997. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5′ end. Virology 235:414-418.
26. Domingo, E. 2003. Quasispecies and the development of new antiviral strategies. Prog. Drug Res. 60:133-158.
27. Domingo, E. 2005. Virus entry into error catastrophe as a new antiviral strategy. Virus Res. 107:115-228.
28. Domingo, E. (ed.). Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol., in press.
29. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96:13910-13913.
30. Dutko, F. J., and M. B. A. Oldstone. 1983. Genomic and biologic variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1694.
31. Eigen, M. 2002. Error catastrophe and antiviral strategy. Proc. Natl. Acad. Sci. USA 99:13374-13376.
32. Escarmís, C., M. Dávila, and E. Domingo. 1999. Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 285:495-505.
33. Escarmís, C., G. Gómez-Mariano, M. Dávila, E. Lázaro, and E. Domingo. 2002. Resistance to extinction of low fitness virus subjected to plaque-to-plaque transfers: diversification by mutation clustering. J. Mol. Biol. 315:647-661.
34. Franze-Fernandez, M. T., S. Iapalucci, R. Lopez, and C. Rossi. 1993. Sub-genomic RNAs of Tacaribe virus, p. 113-132. In M. S. Salvato (ed.), The Arenaviridae. Plenum Press, New York, N.Y.
35. Freistadt, M. S., G. D. Meades, and C. E. Cameron. 2004. Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance? Drug Resist. Updat. 7:19-24.
36. Goff, S. P. 2003. Death by deamination: a novel host restriction system for HIV-1. Cell 114:281-283.
37. González-López, C., A. Arias, N. Pariente, G. Gómez-Mariano, and E. Domingo. 2004. Preextinction viral RNA can interfere with infectivity. J. Virol. 78:3319-3324.
38. Graci, J. D., and C. E. Cameron. 2004. Challenges for the development of ribonucleoside analogues as inducers of error catastrophe. Antivir. Chem. Chemother. 15:1-13.
39. Graci, J. D., and C. E. Cameron. 2002. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology 298:175-180.
40. Grande-Pérez, A., E. Lázaro, P. Lowenstein, E. Domingo, and S. C. Manrubia. 2005. Suppression of viral infectivity through lethal defection. Proc. Natl. Acad. Sci. USA 102:4448-4452.
41. Grande-Pérez, A., S. Sierra, M. G. Castro, E. Domingo, and P. R. Lowenstein. 2002. Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl. Acad. Sci. USA 99:12938-12943.
42. Holland, J. J., E. Domingo, J. C. de la Torre, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64:3960-3962.
43. Hunziker, L., A. Ciurea, M. Recher, H. Hengartner, and R. M. Zinkernagel. 2003. Public versus personal serotypes of a viral quasispecies. Proc. Natl. Acad. Sci. USA 100:6015-6020.
44. Iapalucci, S., N. Lopez, O. Rev, M. M. Zakin, G. N. Cohen, and M. T. Franze-Fernandez. 1989. The 5′ region of Tacaribe virus L RNA encodes a protein with a potential metal binding domain. Virology 173:357-361.
45. Jonsson, C. B., B. G. Milligan, and J. B. Arterburn. 2005. Potential importance of error catastrophe to the development of antiviral strategies for hantaviruses. Virus Res. 107:195-205.
46. Lanford, R. E., D. Chavez, B. Guerra, J. Y. Lau, Z. Hong, K. M. Brasky, and B. Beames. 2001. Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J. Virol. 75:8074-8081.
47. Lazaro, E., C. Escarmis, J. Perez-Mercader, S. C. Manrubia, and E. Domingo. 2003. Resistance of virus to extinction on bottleneck passages: study of a decaying and fluctuating pattern of fitness loss. Proc. Natl. Acad. Sci. USA 100:10830-10835.
48. Lee, C. H., D. L. Gilbertson, I. S. Novella, R. Huerta, E. Domingo, and J. J. Holland. 1997. Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J. Virol. 71:3636-3640.
49. Lewicki, H., A. Tishon, P. Borrow, C. F. Evans, J. E. Gairin, K. M. Hahn, D. A. Jewell, I. A. Wilson, and M. B. Oldstone. 1995. CTL escape viral variants. I. Generation and molecular characterization. Virology. 210:29-40.
50. Loeb, L. A., J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, and J. I. Mullins. 1999. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl. Acad. Sci. USA 96:1492-1497.
51. Loeb, L. A., and J. I. Mullins. 2000. Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res. Hum. Retrovir. 13:1-3.
52. Lukashevich, I. S., M. Djavani, K. Shapiro, A. Sanchez, E. Ravkov, S. T. Nicbol, and M. S. Salvato. 1997. The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. J. Gen. Virol. 78:547-551.
53. Maag, D., C. Castro, Z. Hong, and C. E. Cameron. 2001. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J. Biol. Chem. 276:46094-46098.
54. Mangeat, B., P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
55. Meyer, B. J., and P. J. Southern. 1993. Concurrent sequence analysis of 5′ and 3′ RNA termini by intramolecular circularization reveals 5′ nontemplated bases and 3′ terminal heterogeneity for lymphocytic choriomeningitis virus mRNAs. J. Virol. 67:2621-2627.
56. Meyerhans, A., and J.-P. Vartanian. 1999. The fidelity of cellular and viral polymerases and its manipulation for hypermutagenesis, p. 87-114. In E. Domingo, R. G. Webster, and J. J. Holland (ed.), Origin and evolution of viruses. Academic Press, San Diego, Calif.
57. Murphy, D. G., K. Dimock, and C. Y. Kang. 1991. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 181:760-763.
58. Novella, I. S., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. USA 92:5841-5844.
59. Novella, I. S., and B. E. Ebendick-Corpus. 2004. Molecular basis of fitness loss and fitness recovery in vesicular stomatitis virus. J. Mol. Biol. 342:1423-1430.
60. Nowak, M., and P. Schuster. 1989. Error thresholds of replication in finite populations mutation frequencies and the onset of Muller's ratchet. J. Theor. Biol. 137:375-395.
61. O'Hara, P. J., S. T. Nichol, F. M. Horodyski, and J. J. Holland. 1984. Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell 36:915-924.
62. Oldstone, M. B., M. Salvato, A. Tishon, and H. Lewicki. 1988. Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts. Virology 164:507-516.
63. Oldstone, M. B. A. (ed.). 2002. Current topics in microbiology and immunology, vol. 262 and 263. Arenaviruses I and III. Springer-Verlag, Berlin, Germany.
64. Oldstone, M. B. A. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. lmmunol. 263:83-117.
65. Pariente, N., A. Airaksinen, and E. Domingo. 2003. Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J. Virol. 77:7131-7138.
66. Pariente, N., S. Sierra, and A. Airaksinen. 2005. Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. Virus Res. 107:183-193.
67. Pariente, N., S. Sierra, P. R. Lowenstein, and E. Domingo. 2001. Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J. Virol. 75:9723-9730.
68. Parker, W. B. 2005. Metabolism and antiviral activity of ribavirin. Virus Res. 107:165-171.
69. Pinschewer, D. D., M. Perez, and J. C. de la Torre. 2005. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 79:4519-4526.
70. Poch, O., B. M. Blumberg, L. Bougueleret, and N. Tordo. 1990. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J. Gen. Virol. 71:1153-1162.
71. Ripley, L. S. 1990. Frameshift mutation: determinants of specificity. Annu. Rev. Genet. 24:189-213.
72. Ruiz-Jarabo, C. M., C. Ly, E. Domingo, and J. C. de la Torre. 2003. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:37-47.
73. Salvato, M., P. Borrow, E. Shimomaye, and M. B. Oldstone. 1991. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65:1863-1869.
74. Salvato, M., E. Shimomaye, and M. B. Oldstone. 1989. The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase. Virology 169:377-384.
75. -). Virology 164:517-522.
76. Salvato, M. S., and E. M. Shimomaye. 1989. The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology 173:1-10.
77. Severson, W. E., C. S. Schmaljohn, A. Javadian, and C. B. Jonsson. 2003. Ribavirin causes error catastrophe during Hantaan virus replication. J. Virol. 77:481-488.
78. Seville, N., E. Domingo, and J. C. de la Torre. 2002. Contribution of LCMV towards deciphering biology of quasispecies in vivo. Curr. Top. Microbiol. Immunol. 263:197-220.
79. Sierra, S., M. Dávila, P. R. Lowenstein, and E. Domingo. 2000. Response of foot-and-mouth disease virus to increased mutagenesis. Influence of viral load and fitness in loss of infectivity. J. Virol. 74:8316-8323.
80. Singh, M. K., F. V. Fuller-Pace, M. J. Buchmeier, and P. J. Southern. 1987. Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus. Virology 161:448-456.
81. Snell, N. J. 2001. Ribavirin-current status of a broad spectrum antiviral agent. Expert Opin. Pharmacother. 2:1317-1324.
82. Southern, P. J., M. K. Singh, Y. Riviere, D. R. Jacoby, M. J. Buchmeier, and M. B. Oldstone. 1987. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology 157:145-155.
83. Swetina, J., and P. Schuster. 1982. Self-replication with errors. A model for polynucleotide replication. Biophys. Chem. 16:329-345.
84. Teng, M. N., M. B. Oldstone, and J. C. de la Torre. 1996. Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants. Virology 223:113-119.
85. Turner, P. E., and L. Chao. 1999. Prisoner's dilemma in an RNA virus. Nature 398:441-443.
86. van Poelwijk, F., M. Prins, and R. Goldbach. 1997. Completion of the impatiens necrotic spot virus genome sequence and genetic comparison of the L proteins within the family Bunyaviridae. J. Gen. Virol. 78:543-546.
87. Vieth, S., A. E. Torda, M. Asper, H. Schmitz, and S. Gunther. 2004. Sequence analysis of L RNA of Lassa virus. Virology 318:153-168.
88. Vignuzzi, M., J. K. Stone, and R. Andino. 2005. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res. 107:173-181.
89. Viguera, E., D. Canceill, and S. D. Ehrlich. 2001. In vitro replication slippage by DNA polymerases from thermophilic organisms. J. Mol. Biol. 312:323-333.
90. Wilke, C. O., D. D. Reissig, and I. S. Novella. 2004. Replication at periodically changing multiplicity of infection promotes stable coexistence of competing viral populations. Evol. Int. J. Org. Evol. 58:900-905.
91. Youngner, J. S., and P. Whitaker-Dowling. 1999. Interference, p. 850-854. In A. Granoff and R. G. Webster (ed.), Encyclopedia of virology, vol. 2. Academic Press, San Diego, Calif.
92. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.